COMPOSITION:

Nozma 4 ODT: Each orodispersible tablet contains Montelukast Sodium USP equivalent to Montelukast 4 mg.
Nozma 5 ODT: Each orodispersible tablet contains Montelukast Sodium USP equivalent to Montelukast 5 mg.
Nozma 10 Tablet: Each film-coated tablet contains Montelukast Sodium USP equivalent to Montelukast 10 mg.

INDICATIONS:
Nozma is indicated for the prophylaxis and treatment of chronic asthma and for the relief of symptoms of allergic rhinitis in adults and pediatric patients from 6 month of age and older.